Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.

Authors: Fong, A  Garcia, E  Gwynn, L  Lisanti, MP  Fazzari, MJ  Li, M 
Citation: Fong A, etal., Am J Clin Pathol. 2003 Jul;120(1):93-100.
Pubmed: (View Article at PubMed) PMID:12866378
DOI: Full-text: DOI:10.1309/292N-HAYN-WAVR-EJ37

We immunohistochemically evaluated 94 cases of urothelial carcinoma (UC) of the urinary bladder for the expression of caveolin (Cav)-1 and Cav-2. Neither benign urothelium present in 22 cases nor flat carcinoma in situ present in 10 cases stained for Cav-1 or Cav-2. Thirty-five (37%) of 94 cases and 45 (51%) of 89 cases of UC stained positively for Cav-1 and Cav-2, respectively. The percentages of positive cases for Cav-1 in grades 1, 2, and 3 tumors were 0% (0/6), 0% (0/25), and 56% (35/63), respectively (P < .001), and for Cav-2, 0% (0/6), 13% (3/23), and 70% (42/60), respectively (P < .001). Multivariate analysis showed no significant correlation between tumor stage and Cav-1 or Cav-2 expression after correction for tumor grade. Eighty-two percent (14/17) of cases with squamous differentiation were positive for Cav-1 compared with 43% (20/46) of grade 3 tumors without squamous differentiation (P < .001). These results indicate a positive correlation of the expression of Cav-1 and Cav-2 with tumor grade and squamous features of UC and suggest that Cav-1 and Cav-2 be studied further for a possible role in tumor progression and squamous differentiation.

Annotation

Disease Annotations
RGD Objects Annotated

Additional Information

 
RGD Object Information
RGD ID: 2289110
Created: 2008-01-22
Species: All species
Last Modified: 2008-01-22
Status: ACTIVE